pillbase.ru

Сибрава

Active substance: inclisiran

раствор для подкожного введения, 284 мг, 1.5 мл (original in Russian, GRLS)

RussiaActive

Marketing holder: Новартис Оверсиз Инвестментс АГ

Verified 2026-10-09 · GRLS (Russian state register)

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • LEQVIO
    INJECTION, SOLUTION · INCLISIRAN SODIUM 284 mg/1.5mL
    0078-1000
    Novartis Pharmaceuticals Corporation
EU 1
  • Leqvio
    inclisiran
    EMEA/H/C/005333
    Novartis Europharm Limited
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-38bc-71ee-82dd-82c9dbd2528b;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-48a1-7330-a39c-35df6c1c46a2;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
ЛП-№(000689)-(РГ-RU)
Registration status
Active
Dispensing
Prescription only
Release forms
раствор для подкожного введения, 284 мг, 1.5 мл - шприцы - пачки картонные - По рецепту; (original in Russian, GRLS)
Sources
  • product · GRLS (Russian state register) · ЛП-№(000689)-(РГ-RU) · Verified 2026-10-09
  • registration_status · GRLS (Russian state register) · ЛП-№(000689)-(РГ-RU) · Verified 2026-10-09
  • ingredients.0 · GRLS (Russian state register) · ЛП-№(000689)-(РГ-RU) · Verified 2026-10-09